Speak directly to the analyst to clarify any post sales queries you may have.
The global drug testing market is transforming rapidly, driven by evolving regulatory frameworks, technological innovation, and shifting societal demands for effective substance detection and prevention. For senior decision-makers, understanding these dynamics is crucial in leveraging growth opportunities, optimizing investments, and protecting organizational integrity.
Market Snapshot: Drug Testing Market Size and Forecast
The Drug Testing Market grew from USD 24.94 billion in 2024 to USD 28.11 billion in 2025. It is expected to continue growing at a CAGR of 12.22%, reaching USD 49.83 billion by 2030.
Scope & Segmentation
- Sample Types: Blood (plasma, serum); Hair (body hair, scalp hair); Oral Fluid (stimulated, unstimulated); Sweat; Urine (24-hour collections, spot sampling).
- Technologies: Chromatography (gas, liquid); Immunoassay (ELISA, POC immunoassay); Mass Spectrometry (MALDI, tandem MS); Spectroscopy (FTIR, UV spectroscopy).
- Test Types: Health screening, post-accident screening, pre-employment, random (alcohol and drug random), rehabilitation.
- End Users: Clinics; Commercial Laboratories (clinical labs, reference labs); Forensic Laboratories (government, private); Hospitals; Rehabilitation Centers.
- Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (such as the UK, Germany, UAE, South Africa); Asia-Pacific (such as China, India, Australia, Japan, Vietnam, Singapore).
- Companies Analyzed: Quest Diagnostics, Thermo Fisher Scientific, Roche, Danaher Corporation, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, PerkinElmer, Sysmex Corporation.
Key Takeaways for Senior Decision-Makers
- Regulatory tightening is increasing mandatory drug testing, making compliance and adaptability vital for ongoing service eligibility across industries.
- Investment in high-resolution and point-of-care analytical technologies is essential to balance speed, accuracy, and operational cost-efficiency in contemporary lab workflows.
- Non-invasive collection methods, such as oral fluid and sweat, are gaining momentum, supporting safer and more compliant workplace and clinical testing protocols.
- Data integration—using platforms that unify laboratory management and reporting—improves traceability and enables secure, real-time insights for faster decision-making.
- Collaborative partnerships between laboratories, manufacturers, and regulatory agencies are addressing critical challenges in logistics, certification, and scalability.
- Strategic focus on workforce training and digital expertise is increasingly necessary to leverage machine learning applications and to address growing sample volumes and complexity.
Impact of US Tariffs on Operational Strategy
Recent US tariffs have significantly increased procurement costs for laboratory equipment, consumables, and specialty chemicals, impacting both capital investment and supply chain resilience. Decision-makers should note that facilities are adopting alternative sourcing, supply contracts, and onshore production strategies to mitigate long-term disruptions. Margin pressures are disproportionately affecting smaller labs, prompting industry-wide adoption of localization and supplier diversification.
Methodology & Data Sources
This report combines extensive secondary research (regulatory reviews, industry papers, scientific literature) with primary interviews targeting executives, laboratory directors, and procurement specialists. Data triangulation and expert panel validation ensure accuracy and market relevance.
Why This Report Matters
- Delivers actionable insights into emerging segment trends and regional growth for strategic planning and risk mitigation.
- Supports investment and technology roadmaps by mapping regulatory, competitive, and tariff-influenced market shifts.
- Facilitates executive decisions with reliable, segmented analysis for forecasted and scenario-based planning across diverse stakeholder needs.
Conclusion
The drug testing market’s trajectory is shaped by policy, technology, and collaborative engagement. This analysis empowers organizations to anticipate challenges, capitalize on change, and drive sustainable competitive advantage.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
6.2. PESTLE Analysis
8.2. Blood
8.2.1. Plasma
8.2.2. Serum
8.3. Hair
8.3.1. Body Hair
8.3.2. Scalp Hair
8.4. Oral Fluid
8.4.1. Stimulated
8.4.2. Unstimulated
8.5. Sweat
8.6. Urine
8.6.1. 24 Hour Urine
8.6.2. Spot Urine
9.2. Chromatography
9.2.1. Gas Chromatography
9.2.2. Liquid Chromatography
9.3. Immunoassay
9.3.1. Elisa
9.3.2. Poc Immunoassay
9.4. Mass Spectrometry
9.4.1. Maldi
9.4.2. Tandem Ms
9.5. Spectroscopy
9.5.1. Ftir
9.5.2. Uv Spectroscopy
10.2. Health Screening
10.3. Post Accident
10.4. Pre Employment
10.5. Random
10.5.1. Alcohol Random
10.5.2. Drug Random
10.6. Rehabilitation
11.2. Clinics
11.3. Commercial Laboratories
11.3.1. Clinical Laboratories
11.3.2. Reference Laboratories
11.4. Forensic Laboratories
11.4.1. Government Laboratories
11.4.2. Private Laboratories
11.5. Hospitals
11.6. Rehabilitation Centers
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Quest Diagnostics Incorporated
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. F. Hoffmann-La Roche Ltd
15.3.4. Danaher Corporation
15.3.5. Abbott Laboratories
15.3.6. Siemens Healthineers AG
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. PerkinElmer, Inc.
15.3.9. Sysmex Corporation
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
FIGURE 2. DRUG TESTING MARKET MULTI-LANGUAGE
FIGURE 3. DRUG TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2024
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG TESTING MARKET SIZE, BY BODY HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG TESTING MARKET SIZE, BY SCALP HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG TESTING MARKET SIZE, BY STIMULATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG TESTING MARKET SIZE, BY UNSTIMULATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG TESTING MARKET SIZE, BY 24 HOUR URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG TESTING MARKET SIZE, BY SPOT URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG TESTING MARKET SIZE, BY POC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG TESTING MARKET SIZE, BY MALDI, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG TESTING MARKET SIZE, BY TANDEM MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG TESTING MARKET SIZE, BY FTIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG TESTING MARKET SIZE, BY UV SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG TESTING MARKET SIZE, BY HEALTH SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG TESTING MARKET SIZE, BY POST ACCIDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG TESTING MARKET SIZE, BY PRE EMPLOYMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG TESTING MARKET SIZE, BY ALCOHOL RANDOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG TESTING MARKET SIZE, BY DRUG RANDOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG TESTING MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG TESTING MARKET SIZE, BY PRIVATE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG TESTING MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 94. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. CANADA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 96. CANADA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 97. CANADA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 98. CANADA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 99. CANADA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. CANADA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 101. CANADA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 102. CANADA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 103. CANADA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 104. CANADA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 105. CANADA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 106. CANADA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. CANADA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 108. CANADA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 109. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 185. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 189. GERMANY DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 190. GERMANY DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. GERMANY DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 193. GERMANY DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 194. GERMANY DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 195. GERMANY DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 196. GERMANY DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 197. GERMANY DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. GERMANY DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 200. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. FRANCE DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 202. FRANCE DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 203. FRANCE DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 204. FRANCE DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. FRANCE DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 208. FRANCE DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 209. FRANCE DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 210. FRANCE DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. FRANCE DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 212. FRANCE DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. FRANCE DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 230. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 231. ITALY DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 232. ITALY DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 233. ITALY DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 234. ITALY DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 235. ITALY DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. ITALY DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 237. ITALY DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 238. ITALY DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 239. ITALY DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 240. ITALY DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 241. ITALY DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 242. ITALY DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. ITALY DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. ITALY DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 247. SPAIN DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 248. SPAIN DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 249. SPAIN DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SPAIN DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 255. SPAIN DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 256. SPAIN DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 257. SPAIN DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SPAIN DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 259. SPAIN DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 305. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 306. DENMARK DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 307. DENMARK DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 308. DENMARK DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 309. DENMARK DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 310. DENMARK DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. DENMARK DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 313. DENMARK DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 314. DENMARK DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 315. DENMARK DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 316. DENMARK DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 317. DENMARK DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. DENMARK DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 319. DENMARK DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 335. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 336. QATAR DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 337. QATAR DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 338. QATAR DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 339. QATAR DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 340. QATAR DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 341. QATAR DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 342. QATAR DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 343. QATAR DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 344. QATAR DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 345. QATAR DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 346. QATAR DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 347. QATAR DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. QATAR DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 349. QATAR DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 350. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 351. FINLAND DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 352. FINLAND DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 353. FINLAND DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 354. FINLAND DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 355. FINLAND DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 356. FINLAND DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 357. FINLAND DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 358. FINLAND DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 359. FINLAND DRUG TESTING MARKET SIZE, BY SPECTROSCOPY, 2018-2030 (USD MILLION)
TABLE 360. FINLAND DRUG TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 361. FINLAND DRUG TESTING MARKET SIZE, BY RANDOM, 2018-2030 (USD MILLION)
TABLE 362. FINLAND DRUG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 363. FINLAND DRUG TESTING MARKET SIZE, BY COMMERCIAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 364. FINLAND DRUG TESTING MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 365. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 366. SWEDEN DRUG TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 367. SWEDEN DRUG TESTING MARKET SIZE, BY HAIR, 2018-2030 (USD MILLION)
TABLE 368. SWEDEN DRUG TESTING MARKET SIZE, BY ORAL FLUID, 2018-2030 (USD MILLION)
TABLE 369. SWEDEN DRUG TESTING MARKET SIZE, BY URINE, 2018-2030 (USD MILLION)
TABLE 370. SWEDEN DRUG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 371. SWEDEN DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 372. SWEDEN DRUG TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 373. SWEDEN DRUG TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILL
Samples
LOADING...
Companies Mentioned
The companies profiled in this Drug Testing market report include:- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Abbott Laboratories
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Sysmex Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 180 |
Published | May 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 28.11 Billion |
Forecasted Market Value ( USD | $ 49.83 Billion |
Compound Annual Growth Rate | 12.2% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |